alkalosis are the most effective treatments used to decrease pulmonary arterial pressures in newborns, infants, and children with pulmonary hypertension because they are the only therapies known tc produce potent pu!monay; ~.:ascdi!ation =i?h minima! effects on the systemic circulation (2) (3) (4) . However, their mechanism of action remains unclear. Certainly. a better understanding of the mechanism of their selective pulmonary vasodilation would further our understanding of the regulation of pulmonary vascular tone and potentially lead to new treatments for pulmonary hypertension.
EDNO is a labile humoral factor that has been shown to be an important regulator of pulmonary vascular tone (5) (6) (7) (8) (9) . In addition, inhaled nitric oxide produces potent and selective pulmonary vasodilation in the hypertensive newborn pulmonary circulation (10, 11) . Nitric oxide is synthesized by the vascular endothelium by the oxidation of the guanidine nitrogen moiety of L-arginine (12) . Once synthesized and released. it diffuses into vascular smooth muscle cells, where it activates soluble guanylate cyclase. resulting in increased smooth muscle cell concentrations of cGMP. cGMP then initiates a cascade resulting in smooth muscle relaxation ( 13-1 5) . Recent in ritro and in viva evidence suggests that changes in the production of EDNO may mediate the responses of the pulmonary vasculature to changes in oxygen concentration or pH. For example. in vivo, EDNO inhibition has been shown to attenuate the decrease in pulmonary vascular resistance that occurs with ventilation with oxygen in the late gestation fetus (16. 17) . In addition, studies in isolated pulmonary arterial segments and endothelial cells have shown that changes in oxygen concentration alter EDNO and cGMP activity (18) (19) (20) (21) (22) . Similarlv. studies in isolated svstemic arterial segments and endothelial cklls suggest that changes in pH alter E D~O release (23. 24) .
The purpose of the present study. therefore. was to investigate the potential role of EDNO during pulmonary vasodilation produced by hyperoxia or alkalosis in the intact newborn lamb. To investigate the role of EDNO during hyperoxia-induced pulmonary vasodilation. the hemodynamic effects of ventilation with 100% oxygen were compared during similar degrees of pulmonary hypertension induced by the i.v. infusion of U466 19 (a thromboxane A2 mimic) and Nu-nitro-L-arginine (an EDNO synthesis inhibitor) in eight mechanically ventilated newborn lambs. Similarly, to investigate the role of EDNO during alkalosis-induced pulmonary vasodilation. the hemodynamic effects of hyperventilation (to produce a systemic arterial pH > 7.55) were compared during similar degrees of pulmonary hypertension induced by U466 19 or Nu-nitro-L-arginine. Finally, to eliminate the potential effects of prostaglandin synthesis and release during these experiments, all animals were pretreated with meclofenamic acid, an inhibitor of prostaglandin synthesis.
MATERIALS AND METHODS
Surgicalpreparation. Under local anesthesia with 1 % lidocaine hydrochloride, eight lambs (less than 1 wk of age) had polyvinyl catheters placed in an artery and vein of each hind leg. These catheters were advanced to the descending aorta and the inferior vena cava. respectively. General anesthesia was then induced by having the lamb breathe a mixture of oxygen and halothane (1-2%). After intubation with a 4.5-mm outer diameter endotracheal tube. the lambs were mechanically ventilated with a volume-cycled animal ventilator (Harvard Apparatus. Co.. S. Natick, MA). A left lateral thoracotomy was performed in the 4th intercostal space. Polyvinyl catheters were then placed in the internal thoracic artery and vein. and advanced to the ascending aorta and right atrium. respectively. The pericardium was incised along the main pulmonary trunk. The ductus arteriosus was visualized and ligated. Three Teflon cannulas attached to polyvinyl catheters were then inserted. two into the main pulmonary artery and one into the left atrium. A precalibrated electromagnetic flow transducer (CC Instruments. Los Angeles, CA) was placed around the ascending aorta to measure cardiac output. An 8 French chest tube was placed in the pleural space. The thoracotomy incision was closed in layers. The catheters were filled with heparin sodium, plugged, and brought to the skin along with the transducer cable, where they were protected in a pouch secured to the lamb's flank. After recovery from anesthesia, the lamb was weaned from mechanical ventilation, extubated, and returned to its mother. Daily. the chest tube was aspirated, the catheters were flushed with heparin sodium, and an intramuscular injection of 1 mL of ampicillin suspension was administered. Two d were allowed for recovery. All protocols were approved by the Committee on Animal Research, University of California, San Francisco.
Drug preparation. 9,l I ,Dideoxy-l l a,9a epoxymethano-prostaglandin F2a (U46619) (Sigma Chemical Co., St. Louis, MO) suspended in 95% ethanol was stored at -20°C. Immediately before the study, I00 pg were dissolved in 20 mL of 0.9% saline. Nu-nitro-L-arginine (Sigma Chemical Co.) was suspended in sterile 0.9% saline. Acetylcholine chloride (Iolab Corporation, Claremont, CA) was suspended in sterile 0.9% saline. Meclofenamic acid (Sigma Chemical Co.) was prepared for bolus injection by dissolving 70 mg in 10.6 mL of sterile 0.9%, 0.4 mL of Na2C03 (7.15 g/L), and 8 mL of distilled water. For the continuous infusion, 70 mg of meclofenamic acid was dissolved in 58 mL of 0.9% saline, 2 mL of Na2C03 (7.15 g/L), and 40 mL of distilled water. All solutions were prepared on the day of the study.
Experimental protocol. The pulmonary vasodilating response of hyperoxia and alkalosis were compared during similar degrees of pulmonary hypertension induced by the i.v. infusion of U46619 (a thromboxane A2 mimic) and Nu-nitro-L-arginine (an EDNO synthesis inhibitor). The vasodilating response of acetylcholine (an EDNO-dependent vasodilator) was also compared to assess EDNO inhibition. The lambs were pretreated with meclofenamic acid to eliminate the potential participation of prostaglandin synthesis.
To inhibit prostaglandin synthesis, eight lambs, resting quietly in a sling, were given a 10-mg/kg i.v. injection of meclofenamic acid over 10 min followed by a I-mg/kg/h infusion, which was continued for the duration of the study. This dose has been previously shown to block prostaglandin synthesis (25) . After 4 h of the continuous infusion of meclofenamic acid, the eight lambs were anesthetized with ketamine hydrochloride (-1 mg/ kg/min), intubated with a 4.5-mm outer diameter endotracheal tube, and mechanically ventilated with a pediatric time-cycled, pressure-limited ventilator (Healthdyne Inc., Marietta, GA). Succinylcholine chloride (2 mg/kg/dose) was given intermittently for muscle relaxation. Ventilation with 2 1 % oxygen was adjusted to maintain an arterial Pcoz between 4.5 and 6.0 kPa (35 and 45 torr).
U4661Y-induced pulmonary hypertension. After 45 min of stable normocarbic ventilation with 2 1 % oxygen, baseline hemodynamic variables (pulmonary arterial pressure, systemic arterial pressure, heart rate, cardiac output, and right and left atrial pressures) and systemic arterial blood gases and pH were measured. Then. U466 19 (-2 pg/kg/min) was infused i.v. to increase mean pulmonary arterial pressure to approximately 2 times baseline. After 10 min of steady state pulmonary hypertension. all variables were measured. Then. as the U46619 infusion continued. hyperoxia or alkalosis (selected from a table of random numbers) was induced for 10 min. Normocarbic hyperoxia was induced by increasing the inspired oxygen concentration to 100%. After 10 min of ventilation with 100% oxygen. the hemodynamic variables and systemic arterial blood gases and pH were measured: normocarbic ventilation with 2 1 % oxygen was then resumed. Alkalosis was induced by increasing the ventilatory rate by approximately 100%. After 10 min of alkalosis, the hemodynamic variables and systemic arterial blood gases and pH were measured; then normocarbic ventilation with 21% oxygen was resumed. A 15-min recovery period of normocarbic ventilation with 2 1 % oxygen was allowed between conditions to allow the hemodynamic variables and systemic arterial blood gases and pH to return to precondition values before initiating the next condition. Fifteen min after the second condition. acetylcholine (1.0 pg/kg) was injected i.v. and all the variables were measured at the maximum hemodynamic effect. The infusion of U466 19 was then stopped. Acetylcholine is an endothelium-dependent vasodilator; its vasodilating activity is mediated at least in part by the release of EDNO (5). In the present study, the response of acetylcholine was compared before and after the infusion of Nw-nitro-L-arginine to ensure adequate EDNO synthesis inhibition. Nu-nitro-L-arginine-induced pulmonary hypertension. After a 30-min recovery of stable normocarbic ventilation with 2 1 % oxygen, the hemodynamic variables and systemic arterial blood gases and pH were measured. Then, an i.v. infusion of Nw-nitro-L-arginine ( l .O mg/kg/min) was begun and was continued for 60 min [previous studies showed that this cumulative dose was necessary to attenuate the pulmonary vasodilating effects of acetylcholine and other endothelium-dependent vasodilators (6)]. The dose was then increased (to 1.5-2.0 mg/kg/min) to increase mean pulmonary arterial pressure to approximately 2 times baseline (similar to U46619). After 10 min of steady state pulmonary hypertension, all variables were measured. Acetylcholine (1.0 pglkg) was then injected i.v. to assure adequate EDNO inhibition; all variables were measured at the maximum hemodynamic effect. Ten min later, after the hemodynamic variables had returned to preacetylcholine values, hyperoxia or alkalosis was induced for 10 min as above, allowing a 15-min recovery between conditions. The infusion of Nw-nitro-L-arginine was then stopped. At the end of the study, the lambs were given a lethal dose of pentobarbital sodium followed by bilateral thoracotomy. Catheter placement was confirmed at autopsy.
Measzrrements. Pulmonary Compared with these effects during U466 19-induced pulmonary hypertension. the decreases in mean pulmonary arterial pressure and pulmonary vascular resistance produced either by hyperoxia or by alkalosis were unchanged (Figs. 1 and 2) . However. the decreases in mean pulmonary arterial pressure (from --, 12 . i i 9.0% io 9.6 F 6.4%. 11 < 0.05) and puimvnary vascuiar resistance (from 43.3% + 14.4 to 23.8 + 14.1. p < 0.05) produced by acetylcholine were significantly attenuated during Nw-nitro-Larginine-induced pulmonary hypertension, indicating inhibition of EDNO synthesis.
DISCUSSION
This study in intact newborn lambs indicates that the potent, selective pulmonary vasodilation produced by either hyperoxia or by alkalosis is not mediated through the synthesis and release of EDNO. We found that. during pulmonary hypertension induced by U466 19. hyperoxia and alkalosis selectively decreased pulmonary arterial pressure and pulmonary vascular resistance. However. during a similar degree of pulmonary hypertension induced by Nu-nitro-L-arginine. a specific inhibitor of EDNO synthesis. hyperoxia and alkalosis produced similar decreases in pulmonary arterial pressure and pulmonary vascular resistance at a time when the pulmonary vasodilating effects of acetylcholine (an EDNO-dependent vasodilator) were attenuated.
Although the pulmonary vascular response to oxygen has been extensively studied. its mechanism and the potential factors that modulate its response remain unknown. With the recent evidence that nitric oxide is an important mediator of pulmonary vascular tone. there has been interest in defining the role of nitric oxide in the pulmonary vascular responses to changes in oxygen concentrations. Many studies suggest a role of EDNO in mediating the pulmonary vasculature response to oxygen: however, the conclusions have been conflicting. For example, in adult vascular endothelial cells and isolated muscle preparations. decreasing the oxygen concentration is associated with decreased EDNO activity (18) (19) (20) . However. in perfused lungs and intact animals. EDNO inhibition augments pulmonary vasoconstriction. suggesting that EDNO activity is increased during exposure * Values are mean 2 SD. t p < 0.05 hyperoxia vs previous column.
- to decreasing oxygen concentration (26) (27) (28) (29) . In the fetus, both in vitro and in vivo studies suggest that the normal pulmonary vasodilation that occurs at birth in response to ventilation with oxygen is associated with EDNO activity. For example, increasing oxygen tension is associated with increased EDNO activity in both pulmonary vascular endothelial cells and isolated muscle preparations of near-term ovine fetuses (2 1, 22). Similarly, in intact near-term fetal lambs, Nw-nitro-L-arginine (a EDNO synthesis blocker) inhibits the pulmonary vasodilation that normally occurs at birth with oxygen ventilation (16, 17) . In the intact newborn lamb, however, the present study suggests that hyperoxia-induced pulmonary vasodilation is independent of EDNO activity.
There are several possible reasons for the discrepancy between the results of these fetal studies and the current newborn study. First, it is difficult to correlate specific levels of oxygen tension in vivo that result in physiologic responses to levels of oxygen tension in vitro. Second, the in vivo studies differ for several reasons. The present study investigates the responses of oxygen in the newborn pulmonary circulation previously treated with an inhibitor of prostaglandin synthesis and preconstricted with U46619. This is not analogous to the normally vasoconstricted fetal pulmonary circulation capabie of prostaglandin synthesis. In addition, in the fetal studies, the arterial Poz increased from 18 to 50 torr (2.4 to 6.6 kPa), which may be mediated differently than the pulmonary vascular response of increasing arterial Po2 from 98 to 490 torr ( I 3 to 67 kPa) (16, 17) , and the regulation of the pulmonary vascular response to oxygen of a 3-d-old newborn may change dramatically in the first few days of life after continuous exposure to 21% oxygen. Finally, small decreases in pulmonary arterial pressure in the fetus may result in large increases in pulmonary blood flow because of decreased right to left shunting of blood through the ductal arteriosus. This may result in increased shear stress, which is a known mediator of EDNO release. Therefore, the initial vasodilation in response to oxygen may be independent of EDNO. but the subsequent EDNO release (from shear stress) augments the oxygen-induced pulmonary vasodilation. The fetal pulmonary vascular response to oxygen alone without the resulting increase in shear stress is not known. In intact newborn lambs, there is no communication between the pulmonary and systemic circulations, and cardiac output did not change with hyperoxia. Therefore. oxygen-induced pulmonary vasodilation does not increase pulmonary blood flow and presumably does not change shear stresses.
Although the pulmonary vascular response to alkalosis has been appreciated and used therapeutically for many years, its mechanism and the potential factors that modulate its response remain unknown. Prostacyclin is a potent pulmonary vasodilator that has been implicated as a mediator of the decrease in pulmonary vascular resistance that occurs with ventilation at birth (30) . In addition, mechanical factors and hyperventilation have been reported to increase the synthesis of prostacyclin by the lung (3 1). However, in newborn lambs, indomethacin decreased plasma concentrations of 6-ketoprostaglandin F,,, a major metabolite of prostacyclin, but did not inhibit respiratory alkalosisinduced pulmonary vasodilation (4) . and, in fetal lambs, indomethacin did not inhibit oxygen-induced pulmonary vasodilation (32) . To avoid potential effects of prostaglandin release in the present model, meclofenamic acid was infused to inhibit prostaglandin products. The dose used has previously been shown to significantly decrease plasma prostaglandin Ez concentrations in intact fetal sheep (25) .
Although both respiratory and metabolic alkalosis have similar effects of the pulmonary circulation (33) . respiratory alkalosis was used in the present study because it was reproducible and normal ventilation could be quickly reestablished. The ventilatory rate was changed to produce respiratory alkalosis. but the peak pressures remained the same to minimize changes in mean airway pressure.
The role of EDNO in mediating the pulmonary vascular response to pH is not well established. In vitro studies using aortic endothelial cells or superfused aortic muscle strips suggest that increasing pH was associated with increased EDNO release (23, 24) . In the present study, alkalosis-induced pulmonary vasodilation was not changed by the infusion of Nw-nitro-L-arginine, suggesting that the pulmonary vascular response to alkalosis is independent of EDNO activity.
In the present study, the endothelium-dependent pulmonary vasodilation in response to acetylcholine was attenuated by the infusion of Nw-nitro-L-arginine but was not completely blocked. These findings are consistent with previous in vitro and in viva studies and may reflect either the contribution of additional mechanisms to the vasodilating response of acetylcholine or incomplete EDNO inhibition (6, 8. 34 ).
In conclusion, both hyperoxia and alkalosis produced potent pulmonary vasodilation during U466 19-induced pulmonary hypertension in newborn lambs pretreated with meclofenamic acid. The vasodilation was not inhibited by Nu-nitro-L-arginine at a time when the vasodilating effects of acetylcholine (an EDNOdependent vasodilator) were significantly attenuated, suggesting that hyperoxia-and alkalosis-induced pulmonary vasodilation are independent of EDNO activity. Hyperoxia and alkalosis remain effective therapies for selectively lowering pulmonary arterial pressure in newborns. infants. and children with pulmonary hypertension. However, both modalities are associated with significant morbidity such as oxygen-induced lung injury. barotrauma. and hyperosmolarity (I). Additional investigations into the mechanism of these selective. potent pulmonary vasodilators may lead to an increased understanding of the regulation of pulmonary vascular tone and potential newer. less toxic therapies for pulmonary hypertensive disorders.
